Portfolio company
Levation
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops a topical oxymetazoline gel to treat drooping upper eyelids in patients with acquired blepharoptosis or seeking cosmetic eye lifts.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kedalion Therapeutics
This company develops electromechanical ocular delivery devices for patients with eye conditions requiring precise topical medication administration.
Orasis Pharmaceuticals
This company develops prescription eye drops for adults with age-related blurry near vision.
Oculis
This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.
Azura Ophthalmics
This biopharmaceutical company develops ophthalmic keratolytics to treat patients suffering from meibomian gland dysfunction and other ocular surface diseases.
Eyevance Pharmaceuticals
This company develops and commercialises prescription ophthalmic products to treat ocular surface diseases for ophthalmologists, optometrists and their patients.
Tavo Biotherapeutics
The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.
Healome Therapeutics
The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.
Healome
Healome Therapeutics develops eye-drop matrix technology that restructures on the ocular surface to provide long-acting lubrication and drug delivery for patients with eye diseases.
